Masthead

Cover Image - Metabolism - Clinical and Experimental, Volume 142, Issue
Current Issue
Metabolism - Clinical and Experimental
May 2023Volume 142

Current Issue Links

Articles in Press

View All

Issue Highlights

Free Featured Articles

About

Metabolism - Clinical and Experimental

Cover Image - Metabolism - Clinical and Experimental, Volume 142, Issue

Metabolism promotes excellence in research by publishing high-quality original research papers, fast-tracking cutting-edge papers, research brief reports, mini-reviews, and other special articles related to all aspects of human metabolism. Work considered for publication in Metabolism includes studies in humans, animal and cellular models. Work with strong translational potential is prioritized. Metabolism will consider papers for publication in any aspect of translational and clinical metabolic research, including (but not limited to):

More

Metrics

Metrics

##
Impact Factor
##
5-Year Impact Factor
##
Eigenfactor Score

Editor-in-Chief

Photo of Editor Christos S. Mantzoros

Christos S. Mantzoros, MD, DSc, PhD h.c. mult

Christos S. Mantzoros, MD, DSc, PhD h.c. mult. is a Professor of Medicine at Harvard Medical School and adj. Professor at the Boston University School of Medicine.

Dr. Mantzoros obtained an MD and DSc from the University of Athens Medical School, a Master's in Clinical Epidemiology from Harvard School of Public Health and a Master’s in Medical Sciences from Harvard Medical School and he graduated from the Combined Harvard Training program in Endocrinology, Diabetes and Metabolism. He obtained Board certification in Internal Medicine, Endocrinology, Diabetes and Metabolism and in Clinical Nutrition. He had also served in the past as a Professor of Environmental Health at the Harvard School of Public Health.

More

Editor's Note

Dear Friends and Colleagues,

As Editor-in-Chief of Metabolism: Clinical and Experimental, I'm happy to share great news about the journal.

Our Impact Factor has been continuously increasing over the past eleven years that I have been serving at the helm, and is now at 13.934, placing the journal amongst the top 4% of endocrinology, diabetes, and metabolism journals as indexed in Journal Citation Reports*.

This could not have happened without the dedication and expertise of the journal’s Editorial Board members as well its many reviewers and authors, to whom we are particularly thankful.

More

COVID-19 and Metabolic Syndrome: A Call To Action

The COVID-19 pandemic presents an unprecedented health crisis to the entire world. As in many other instances, people with metabolic syndrome (obesity, hypertension, hyperlipidemia, and diabetes) are apparently paying a very high price.

Data, albeit mostly uncontrolled for potential confounding factors, are, unfortunately, showing that people with underlying metabolic conditions are at higher risk of both contracting COVID-19 and having a worse prognosis. At the same time, in such a sudden health crisis, it is not clear what the most appropriate management would be and thus most likely these patients may not be receiving the most appropriate care when hospitalized.

Metabolism is committed to playing a positive role during this crisis. We the Editors invite the submission of papers addressing this topic and remain committed to a fast-track quality process for the review of any relevant research on COVID-19 and guarantee free access to accepted papers.

More

Metabolism Awards

Dr. Jihoon Shin

Junior Faculty Members

The winner of the 2023 Metabolism Award for Junior Faculty Members is Dr Jihoon Shin. He wins the $1500 annual prize for the paper “SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1” which was selected by a panel of experts from all eligible entries published in the journal in 2022.

Dr Jihoon Shin received his Ph.D. degree at the Department of Metabolic Medicine, Graduate School of Frontier Biosciences, Osaka University, JAPAN. He is currently an Assistant Professor of Diabetes Care Medicine at the Graduate School of Medicine/Faculty of Medicine, Osaka University, Japan.

Dr. Hexiang Peng

Junior Investigators

The winner of the 2023 Metabolism Award for Junior Investigators is Dr. Hexiang Peng. She wins $1500 for the paper “Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study”, which was selected by a panel of experts from all eligible entries published in the journal in 2022.

Dr Hexing Peng received her master's degree from the School of Public Health at Peking University. She is currently pursuing her PhD in Epidemiology and health Statistics at Peking University School of Public Health. Her research interests include genetic epidemiology and chronic disease epidemiology.

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)

Advertisement

The content on this site is intended for healthcare professionals.


We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


RELX